System for generating a non-fungible token including mutable and immutable attributes and related methods
US-12469042-B1 · Nov 11, 2025 · US
This page is not indexed by search engines while we improve data quality.
Wheeler John patents
Wheeler John is listed as an inventor on 29 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Wheeler John |
| Total patents | 29 |
| First publication | May 7, 2015 |
| Latest publication | Nov 11, 2025 |
Notable patents
Publications ranked by popularity score, then publication date.
Anti-PHF-tau antibodies and uses thereof
US-12234280-B2 · Feb 25, 2025 · US
Human Anti-CD27 Antibodies
US-2024141055-A1 · May 2, 2024 · US
Neutralizing human anti-CD27 antibodies
US-11732050-B2 · Aug 22, 2023 · US
Anti-ccl17 antibodies
US-2022348647-A1 · Nov 3, 2022 · US
Anti-CCL17 antibodies
US-11414484-B2 · Aug 16, 2022 · US
Anti-phf-tau antibodies and uses thereof
US-2021002358-A1 · Jan 7, 2021 · US
Human Anti-CD27 Antibodies
US-2020277393-A1 · Sep 3, 2020 · US
Methods of inhibiting naive T-cell proliferation using anti-CD27 antibodies
US-10689453-B2 · Jun 23, 2020 · US
Anti-PHF-tau antibodies and uses thereof
US-10633435-B2 · Apr 28, 2020 · US
Recent patents
Latest publications not already listed above.
ST2L antagonists and methods of use
US-10450377-B2 · Oct 22, 2019 · US
Anti-PHF-Tau Antibodies and Uses Thereof
US-2019270793-A1 · Sep 5, 2019 · US
Methods of Inhibiting Activity Using Anti-CD27 Antibodies
US-2019248910-A1 · Aug 15, 2019 · US
Methods of inhibiting T-cell mediated B-cell antibody production using anti-CD27 antibodies
US-10301392-B2 · May 28, 2019 · US
St2l antagonists and methods of use
US-2019062439-A1 · Feb 28, 2019 · US
ST2L antagonists and methods of use
US-9951137-B2 · Apr 24, 2018 · US
Anti-CCL17 antibodies
US-9944697-B2 · Apr 17, 2018 · US
CD123 binding agents and uses thereof
US-9850310-B2 · Dec 26, 2017 · US
Methods of Inhibiting Activity Using Anti-CD27 Antibodies
US-2017320957-A1 · Nov 9, 2017 · US
Nucleic acid molecules encoding anti-CD27 antibodies
US-9683046-B2 · Jun 20, 2017 · US
ST2L Antagonists and Methods of Use
US-2017066831-A1 · Mar 9, 2017 · US
CD123 Binding Agents and Uses Thereof
US-2016068605-A1 · Mar 10, 2016 · US
Affinity peptides toward infliximab
US-9248194-B2 · Feb 2, 2016 · US
ST2L antibody antagonists for the treatment of ST2L-mediated inflammatory pulmonary conditions
US-9212227-B2 · Dec 15, 2015 · US
Human Anti-CD27 Antibodies, Methods and Uses
US-2015299330-A1 · Oct 22, 2015 · US
Human anti-CD27 antibodies, methods and uses
US-9102737-B2 · Aug 11, 2015 · US
ST2L antibody antagonists
US-9090694-B2 · Jul 28, 2015 · US
Generation of human de novo pIX phage display libraries
US-9062305-B2 · Jun 23, 2015 · US
Anti-CCL17 Antibodies
US-2015125458-A1 · May 7, 2015 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Janssen Biotech Inc | 22 |
| Janssen Pharmaceutica Nv | 4 |
| Janssen Pharmaceutica Nv | 2 |
| Barone Linda | 1 |
| Jansson Biotech Inc | 1 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61K2039/505 | 27 |
| C07K2317/565 | 26 |
| C07K2317/92 | 23 |
| C07K2317/76 | 21 |
| A61P11/00 | 20 |